Catium ES 110 mcg+50 mcg (Inhalation Capsule)
Unit Price: ৳ 50.00 (5 x 6: ৳ 1,500.00)
Strip Price: ৳ 300.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Indacaterol glycopyrronium |
| Company | Incepta pharmaceuticals ltd |
| Also available as |
Indications
- Long-term once-daily maintenance bronchodilator treatment
- Airflow obstruction in COPD patients
- Chronic bronchitis treatment
- Emphysema treatment
Composition
- Each dry powder inhaler capsule contains Indacaterol 110 mcg
- Indacaterol Maleate INN
- Glycopyrronium 50 mcg
- Glycopyrronium Bromide BP
Pharmacology
- Combination of Glycopyrronium (an anticholinergic) and Indacaterol (a LABA)
- Stimulation of intracellular adenyl cyclase
- Relaxation of bronchial smooth muscle
- Inhibition of release of mediators of immediate hypersensitivity
Dosage & Administration
- For oral inhalation only
- Maintenance treatment of COPD: 1 inhalation once daily
- Limitations: Not for acute bronchospasm relief or asthma treatment
- Geriatric use
- Use in Children & Adolescents
- Renal impairment
- Hepatic impairment
Interaction
- No specific interaction studies conducted for Glycopyrronium and Indacaterol combination
- Contraindications for concomitant use with β-adrenergic blockers or anticholinergics
- Caution with hypokalemic treatment
Contraindications
- Hypersensitivity to Glycopyrronium or Indacaterol
- Severe hypersensitivity to milk proteins
- Contraindicated in asthma without long-term control medication
Side Effects
- Cardiovascular effects
- Ocular disorders
- Urinary retention
- Gastrointestinal disorders
- Dry mouth
- Cough
- Hypersensitivity reactions
- Headache
- Nervousness
- Insomnia
- Muscle spasms
- Fatigue
- Malaise
Pregnancy & Lactation
- Pregnancy category C
- Limited data on use during pregnancy
- Unknown excretion in human milk
Precautions & Warnings
- Increased risk of serious asthma-related events with LABA monotherapy
- Use with caution in cardiovascular disorders
- Worsening of narrow-angle glaucoma
- Worsening of urinary retention
- Alert to hypokalemia and hyperglycemia
Overdose Effects
- No information on clinically relevant overdosing with medication
- Potential effects: tachycardia, tremor, palpitations, nausea, vomiting, drowsiness, ventricular arrhythmias
- Anticholinergic effects: increased intraocular pressure, obstipation, difficulties in voiding
- Supportive and symptomatic treatment indicated
Therapeutic Class
- Combined bronchodilators
Storage Conditions
- Avoid storage in direct sunlight or heat
- Store in a cool & dry place
- Keep away from eyes
- Keep out of reach of children